In addition, PADI4 siRNA therapy together with 5-FU treatment enhanced the siRNA inhibitory effect on gastric cancer cell proliferation, suggesting that this combinatory regimen may help reduce the drug resistance of gastric cancer cells and improve therapeutic efficacy [233]. This evidence concerns the gene PADI4 and gastric cancer.